Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amblyopia Treatment Study (ATS)
NCT00001864Phase 3Completed
- Sponsor
- National Eye Institute
- Start
- May 1999
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atropine in amblyopia, sponsored by National Eye Institute. Started May 1999; status: completed.
02
Drugs
atropine
03
Conditions
amblyopia
Beyond the preview
Go deeper on NCT00001864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001864.